O. Eickelberg (Munich, Germany), P. Bonniaud (Dijon, France), M. Keane (Dublin, Ireland), G. Cox (Hamilton, Canada)
Ambrisentan attenuates lung and heart injury in a rat model of bronchopulmonary dysplasia
G. Wagenaar, Y. de Visser, E. H. Laghmani, F. Walther (Leiden, Netherlands)
|  |
Serum HSP47 is a novel blood marker for rapidly progressive interstitial pneumonia
T. Kakugawa, S. I. Yokota, Y. Ishimatsu, T. Hayashi, S. Nakashima, S. Hara, N. Sakamoto, H. Kubota, M. Mine, Y. Matsuoka, H. Mukae, K. Nagata, S. Kohno (Nagasaki, Sapporo, Kyoto, Akita, Kitakyushu, Japan)
| |
Protease-activated receptor-2 triggers epithelial to mesenchymal transition: Potential relevance in pulmonary fibrosis
K. Borensztajn, J. von der Thüsen, M. Peppelenbosch, A. Spek (Amsterdam, Rotterdam, Netherlands; London, United Kingdom)
| |
Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice
Y. J. Li, T. Shimizu, Y. Hirata, H. Inagaki, A. Azuma, H. Takizawa, S. Takahashi, M. Yamamoto, T. Kawada, S. Kudoh (Tokyo, Kawasaki, Ibaragi, Sendai, Kiyose, Japan)
| |
αB-crystallin is involved in the process of pulmonary fibrosis
P. S. Bellaye, G. Wettstein, C. Garrido, J. Gauldie, M. Kolb, P. Camus, P. Bonniaud (Dijon, France; Hamilton, Canada)
| |
Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis
N. Borsonello, A. P. Velosa, P. Martin, R. Marangoni, S. Carrasco, E. Parra, V. Capelozzi, N. Yoshinari, W. Teodoro (São Paulo, Brazil)
| |
Work of inflation is the best correlate to lung fibrosis induced by bleomycin in mice
J. E. Phillips, R. Peng, G. Tyagi, R. Garrido, L. Burns, P. Harris, J. S. Fine, C. S. Stevenson (Nutley, United States Of America)
| |
Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis
T. Shiobara, H. Hirata, Y. Fukushima, M. Tatewaki, F. Fukushima, K. Chibana, K. Sugiyama, M. Arima, K. Kurasawa, T. Fukuda (Mibu-machi, Shimotsuga-gun, Chiba, Japan)
| |
Enhanced acute pulmonary inflammation and reduced fibrotic response in quartz-exposed p47phox-deficient mice
C. Albrecht, D. van Berlo, A. Boots, A. Wessels, V. Wilhelmi, A. Scherbart, K. Gerloff, F. Huaux, A. Bast, R. Schins (Duesseldorf, Germany; Maastricht, Netherlands; Brussels, Belgium)
| |
Muscarinic receptor stimulation differentially regulates extracellular matrix gene expression in lung fibroblasts
B. Dekkers, R. Gosens, J. Zaagsma, H. Meurs (Groningen, Netherlands)
|  |
Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis
P. Martin, A. P. Velosa, A. Santos, S. Carrasco, A. Santos, E. Parra, C. Goldenstein-Schainberg, N. Yoshinari, V. Capelozzi, T. Walcy (São Paulo, Brazil)
| |
The effect of erythropoietin (EPO) on cyclooxygenase-2 (COX-2) and cytochrome-c (CYT-c) in the bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
D. Tsavlis, A. Tzoumaka, G. Kokaraki, K. Kouzi-Koliakos, I. Angomachalelis, A. Tektonidou, D. Koutsonikolas, E. Spandou (Thessaloniki, Greece)
| |
Microparticles-associated tissue factor activity is increased in bronchoalveolar lavage of patients with pulmonary fibrosis and correlates with functional impairment
F. Novelli, T. Neri, C. Noce, L. Tavanti, S. Cini, F. Martino, A. Celi, P. Paggiaro (Pisa, Italy)
| |
Study of tetrahydrobiopterin in idiopathic pulmonary fibrosis and COPD
P. Almudéver Folch, A. De Diego Damia, J. Cortijo Gimeno, M. León Fábregas, M. J. Fandós, X. Milara (Valencia, Spain)
| |
Increase of nitrosative stress in patients with eosinophilic pneumonia
K. Furukawa, H. Sugiura, K. Matsunaga, T. Ichikawa, A. Koarai, T. Hirano, M. Ichinose (Wakayama, Japan)
| |
Molecular mechanism of lung aging in senescence-accelerated mouse (SAM)
Y. Yuan, X. Hu, L. Luo, M. Yang, Z. Su, X. Zhang (Chengdu, China)
| |
Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction
H. Ilumets, W. Mazur, T. Toljamo, N. Louhelainen, P. Nieminen, H. Kobayashi, N. Ishikawa, V. Kinnula (Helsinki, Rovaniemi, Oulu, Finland; Tokorozawa, Hiroshima, Japan)
| |
Endothelial dysfunction in preterm infants with respiratory disorders
O. Mazulov, Y. Kyslova, O. Yablon (Vinnitsa, Ukraine)
| |
Neutral sphingomyelinase 2 (nSMase2) has a protective role in emphysema
C. Poirier, N. Bogatcheva, C. Dimitropoulou, P. Biddinger, A. Verin (Augusta, United States Of America)
| |
Late intervention with a myeloperoxidase inhibitor prevents emphysema and small airway remodeling in the guinea pig
A. Churg, C. Marshall, D. Sin, E. Cadogan, M. Soars, S. Bolton, J. Maltby, P. Mallinder, J. Wright (Vancouver, Canada; Charnwood, United Kingdom)
| |